ArticleACR open rheumatology2025

Correction to "Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies".

No numbers read from the abstract.

Not cited yet